Ferrous fumarate-induced malabsorption of thyroxine

Endocrinologist

Volumn 9, Issue 6, 1999, Pages 493-495

  Leger, Chantal S ^a   Ooi, Teik Chye ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS FUMARATE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG METABOLISM; FEMALE; HUMAN; HYPOTHYROIDISM; IRON THERAPY; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

EID: 2442737833     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199911000-00011     Document Type: Article

References (8)

1. Fish LH, Schwartz HL, Cavanaugh J, et al.: Replacement dose, metabolism and bioavailability of levothyroxine in the treatment of hypothyroidism. N Engl J Med 1987; 316: 764-70.
2. Hays MT: Absorption of oral thyroxine in man. J Clin Endocrinol Metab 1968; 28: 749-56.
3. Northcutt RC, Stiel JN, Hollifeld JW, et al.: The influence of cholestyramine on thyroxine absorption. J Am Med Assoc 1969; 208: 1857-61.
4. Sperber AD, Liel Y: Evidence for interference with the intestinal absorption of levothyroxine sodium by alluminum hydroxide. Arch Intern Med 1992; 152: 183-4.
5. Sherman SI, Tielens ET, Ladenson PW, et al.: Sucralfate causes malabsorption of L-Thyroxine. Am J Med 1994; 96: 531-5.
6. Liel Y, Harman-Boehm I, Shany S, et al.: Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab 1996; 80: 857-9.
7. Shakir KM, Chute JP, Aprill BS, et al.: Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J 1997; 90: 637-9.
8. Campbell NR, Hasinoff BB, Stalts H, et al.: Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992; 117: 1010-3.